
CHROMOSOMAL POLYMORPHISMS INVOLVED IN
REPRODUCTIVE FAILURE IN THE ROMANIAN POPULATION Mierla D1,2*, Stoian V2 *Corresponding Author: Dana Mierla MD, Department of Genetics, Faculty of Biology, University of Bucharest,
Bucharest, Romania; Tel.: +40721479083; E-mail: dana_mierla@yahoo.com page: 23
|
RESULTS
Cytogenetic analysis revealed a number of
numerical and structural abnormalities, but in this
study only chromosomal polymorphisms involved
in infertility are reported (Table 1). Chromosomal
polymorphism were found in 122/1809 (6.74%) infertile
patients in the study group and 63/1116 (5.65%)
fetuses in the control group; this was not statistically
significant (p = 0.24) (Figure1). The difference between
the patients and controls for some specific chromosomal
polymorphisms is statistically significant
[e.g., inv(9), 1qh+, 9qh+, fra(17)]. This shows that
there was a noteworthy relation at risk of infertility
and polymorphic variants. The frequencies, according
to our study, of the chromosomal polymorphisms for
patients and controls are shown in Table 2. The most
common variant observed in infertile couples was
inv(9) (2.27%). Other chromosomal variants with a
high incidence were 1qh+ (1.22%) and 9qh+ (1.11%).
The least common polymorphic variations in infertile
couples were usually observed in the para-centric
heterochromatin on the long arms of chromosomes
16, 16qh+ (0.28%), the short-arm of the D and G
groups of chromosomes 15ps+ (0.22), 21ps+ (0.33),
22ps+ (0.44%), and the distal heterochromatin of the Y chromosome, Yqh+ (0.16%). The frequency of heteromorphisms
in females was 2.76% and 3.98% in
males. Twenty males who had heteromorphisms were
oligozoospermic or azoosper-mic. The seven women
with chromosome heteromor-phisms had normospermic
partners. As for the 1116 amniocentesis samples
studied, we detected female karyotypes in 533 and
male karyotypes in 583 fetuses. We observed polymorphisms
in 63 fetuses (5.65%), 30 (1.65%) female
and 33 (1.87%) male fetuses. The most frequent types
of heteromorphisms in the control group were inv(9)
at 3.76%, followed by 1qh+, 9qh+ and 16qh+ variants
(0.36, 0.18 and 0.36%, respectively), followed by D
and G group variants.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|